# Myovant Sciences (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/myovant-sciences-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 22 |
| Citations | 6,908 |
| City | Brisbane |
| Country | US |
| Description | Myovant Sciences (United States) is a research organisation in Brisbane, US. OpenAlex records 223 works and 6,908 citations for it. 86 researchers list it as their most recent affiliation. |
| Homepage | http://myovant.com/ |
| OpenAlex ID | https://openalex.org/I4210151376 |
| Region | California |
| Researchers | 86 |
| ROR ID | https://ror.org/04p31sb09 |
| Type | company |
| Works | 223 |

## University papers

- [Atopic dermatitis in the pediatric population](https://scholariq.org/papers/atopic-dermatitis-in-the-pediatric-population/)
- [The atopic march and atopic multimorbidity: Many trajectories, many pathways](https://scholariq.org/papers/the-atopic-march-and-atopic-multimorbidity-many-trajectories-many-pathways/)
- [The moonlighting enzyme CD13: old and new functions to target](https://scholariq.org/papers/the-moonlighting-enzyme-cd13-old-and-new-functions-to-target/)
- [Losing your nerves? Maybe it's the antibodies](https://scholariq.org/papers/losing-your-nerves-maybe-it-s-the-antibodies/)
- [Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)](https://scholariq.org/papers/report-from-the-fifth-international-consensus-meeting-to-harmonize-core-outcome/)
- [CD13/APN regulates endothelial invasion and filopodia formation](https://scholariq.org/papers/cd13-apn-regulates-endothelial-invasion-and-filopodia-formation/)
- [CD13 is a novel mediator of monocytic/endothelial cell adhesion](https://scholariq.org/papers/cd13-is-a-novel-mediator-of-monocytic-endothelial-cell-adhesion/)
- [Suppression of Glomerulonephritis in Lupus‐Prone NZB × NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase](https://scholariq.org/papers/suppression-of-glomerulonephritis-in-lupus-prone-nzb-nzw-mice-by-rn486-a/)
- [Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial](https://scholariq.org/papers/clinically-meaningful-responses-to-dupilumab-in-adolescents-with-uncontrolled/)
- [Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide](https://scholariq.org/papers/disease-trajectories-in-childhood-atopic-dermatitis-an-update-and-practitioner-s/)
- [Real-world treatment utilization and economic implications of lupus nephritis disease activity in the United States](https://scholariq.org/papers/real-world-treatment-utilization-and-economic-implications-of-lupus-nephritis/)

## University researchers

- [Paola Mina‐Osorio](https://scholariq.org/researchers/paola-mina-osorio/)

## University top topics

Showing 8 of 25.

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Endometriosis Research and Treatment](https://scholariq.org/topics/endometriosis-research-and-treatment/)
- [Uterine Myomas and Treatments](https://scholariq.org/topics/uterine-myomas-and-treatments/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)
- [Hormonal and reproductive studies](https://scholariq.org/topics/hormonal-and-reproductive-studies/)
- [Gynecological conditions and treatments](https://scholariq.org/topics/gynecological-conditions-and-treatments/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Pelvic floor disorders treatments](https://scholariq.org/topics/pelvic-floor-disorders-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.